e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Nontuberculosis mycobacteria infections: would there be pharmacodynamics without pharmacokinetics?
Nakwon Kwak, Margareth Pretti Dalcolmo, Charles L. Daley, Geoffrey Eather, Naoki Hasegawa, Won-Jung Koh, Rachel Thomson, Jakko van Ingen, Jae-Joon Yim
Source:
Eur Respir J, 54 (5) 1901806; 10.1183/13993003.01806-2019
Journal Issue:
November
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Nakwon Kwak, Margareth Pretti Dalcolmo, Charles L. Daley, Geoffrey Eather, Naoki Hasegawa, Won-Jung Koh, Rachel Thomson, Jakko van Ingen, Jae-Joon Yim. Nontuberculosis mycobacteria infections: would there be pharmacodynamics without pharmacokinetics?. Eur Respir J, 54 (5) 1901806; 10.1183/13993003.01806-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Levofloxacin pharmacokinetics, pharmacodynamics and outcome in multidrug-resistant tuberculosis patients
Source: Eur Respir J, 53 (4) 1802107; 10.1183/13993003.02107-2018
Year: 2019
Pharmacokinetics of drugs for non tuberculous mycobacterial lung infections
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012
Pharmacokinetics of ertapenem in patients with multidrug-resistant tuberculosis
Source: Eur Respir J 2016; 47: 1229-1234
Year: 2016
The tolerability of linezolid in the treatment of nontuberculous mycobacterial disease
Source: Eur Respir J 2015; 45: 1177-1179
Year: 2015
Pharmacokinetics and pharmacodynamics of newer fluoroquinolones in patients with lower respiratory tract infections
Source: Annual Congress 2012 - Management of severe respiratory infections
Year: 2012
Pharmacokinetics of moxifloxacin and linezolid during and after pregnancy in a patient with multidrug-resistant tuberculosis
Source: Eur Respir J , 49 (3) 1601724; DOI: 10.1183/13993003.01724-2016
Year: 2017
Nontuberculous mycobacteria infections in patients receiving immunosuppressive agents
Source: Eur Respir Monogr 2018; 81: 238-253
Year: 2018
Newer fluoroquinolones for treating respiratory infection: do they mask tuberculosis?
Source: Eur Respir J 2010; 35: 606-613
Year: 2010
Efficacy and safety of linezolid for the treatment of multidrug resistant tuberculosis (MDR-TB) and disease by non tuberculous mycobacteria (NTM)
Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions
Year: 2011
Population pharmacokinetics and pharmacodynamics of meropenem in elderly Chinese with lower respiratory tract infection
Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections
Year: 2010
In vitro susceptibility of non-tuberculous mycobacterial strains against moxifloxacin
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools
Year: 2012
Infection or colonisation: indicators to initiate antimycobacterial treatment in nontuberculous mycobacterial infections
Source: Annual Congress 2010 - Advances in the diagnosis of tuberculosis and nontuberculous mycobacterial infections: a joint ERS and ATS symposium
Year: 2010
Bedaquiline in the treatment of multi-drug resistant non-tuberculous mycobacteria soft tissue infections: a case series
Source: Virtual Congress 2021 – Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease
Year: 2021
Evaluation of moxifloxacin for the treatment of tuberculosis: 3 years of experience
Source: Eur Respir J 2011; 38: 888-894
Year: 2011
A randomized, open-label, multicenter study of liposomal amikacin for inhalation in adult patients with nontuberculous mycobacteria (NTM) lung infections caused by mycobacterium avium complex (MAC)
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015
Nontuberculous mycobacteria in non-HIV patients: epidemiology, treatment and response
Source: Eur Respir J 2004; 23: 741-746
Year: 2004
Safety of intravenous amikacin in the treatment of pulmonary non-tuberculous mycobacterial disease
Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Year: 2013
Population pharmacokinetics and pharmacodynamics analysis of vancomycin in patients with severe lower respiratory tract gram-positive infections
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014
Efficacy and safety of azithromycin vs. clarithromycin for the treatment of community-acquired pneumonia due to
legionella pneumophila
Source: Annual Congress 2004 - Community acquired pneumonia - epidemiology and host defence
Year: 2004
Pathogenicity of NTM: new developments
Source: Annual Congress 2007 - Nontuberculous mycobacteria (NTM): a slow-growing challenge
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept